In August CTS begins source plasma testing as a new line of business to one of the largest plasma fractionators in the industry.
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.
In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....